ArticleOncotarget2016

CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX.

Wenting Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.